Title: Workshop: New Developements in International Photomedicine

Biography:

Detlef Schikora has completed the study of physics and medicine and dissertation A and B at Humboldt University of Berlin, Germany in 1974.

He is the University lecturer since 1994 and Head of the biophysics research group at the Faculty of Science of the Paderborn University Germany. He has published 144 original scientific papers.  He is an author of the compendium, Laserneedle-Acupuncture: Science and Practice, Pabst Science Publishers, Lengerich, 2004. Also an author of the "Laserneedle Therapy Handbook" laneg publishers Berlin, 2013. He has awarded in 2004 with the “International Research Award” of the Medical Acupuncture Research Foundation (MARF) and the American Association of Medical Acupuncture (AAMA) of the United States of America”. He is the inventor of a patented photomedical treatment procedure and technology " mitochondrial excitation due to lowering of ligth absorption = medlouxx " in 2012 and also the Inventor of a patented photodynamic diagnosis and treatment method, Photodynamic Infrared Spectroscopy”, PDIS, in 2017.

Abstract

The workshop demonstrates the integrative combination of phototherapy and laser acupuncture in the treatment of dry, age related macular degeneration. For the first time, we have shown in a randomized clinical trial the complete and stable healing of that frequent diseases. We explan the healing principles, which are based on cellular oxidative stress. In a second part of the workshop we demonstrate modern pain treatment strategies, which are stimulating central pain inhibiting pathways and combine it with photonic blockade of lateral nerve fibres. In the third part of the workshop we introduce the new PDIS-method (photodynamic infrared spectroscopy) for cancer diagnosis and treatments. The PDIS is able to detect single circulating tumor cells (CTCs) in the blood and can destroy CTCs. As consequence, the formatiion of metastases can be effectively avoided and -as result- the cancer mortality rate can be reduced.  Furthermore, the PDIS allows to evaluate the results of any chemotherapy/radiation therapy. The uncertainity regarding the patients lifetime prognosis can be finished and individually adapted treatment strategies can be developed and applied.